Preparation and Characterization of Febuxostat as Nanosuspension by Zahraa Salim Alwan, Nawal Ayash Rajab

Subjects: “…Febuxostat, L-arginine, Nanosuspension…”
Get full text

Febuxostat in the therapy of gout: from theory to practice by E. V. Ilyinykh, S. A. Vladimirov, M. S. Eliseev

Subjects: Get full text

Cardiovascular safety of febuxostat. Analysis of the CARES study by M. S. Eliseev

Subjects: Get full text

Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study by Min Jung Kim, Jung Yoon Pyo, Se Rim Choi, Anna Shin, Hokyung Choung, You-Jung Ha, Yun Jong Lee, Eun bong Lee, Eun Ha Kang

Subjects: “…Febuxostat…”
Get full text

Study on the Frequency and Factors Affecting Treatment Discontinuation in Gout Patients in Sari, 2023–2024 by Yasaman Salehi, Maryam Mobini, Fatemeh Niksolat, Aref Hoseinian, RezaAli Mohammadpour

Subjects: Get full text

Expressions of nephrin and desmin in podocyte of HUA rats and intervention of febuxostat by Wu Wei-bin, Zhang Ji-qiang, Gao Qin, Yin Xiao-li, Sang Miao-miao, Yang Ping, Liu Lei, Chen Wei-dong

Subjects: Get full text

A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout by Ting-Syuan Lin, Ting-Syuan Lin, Yen-Liang Lin, Yen-Liang Lin, Chiu-Hao Hsu, Chiu-Hao Hsu, Song-Chou Hsieh, Wen-Yi Shau, Wei-Shiung Yang, Wei-Shiung Yang, Chi-Ling Chen, Chi-Ling Chen, Chi-Ling Chen

Subjects: “…febuxostat…”
Get full text

The effect of uric acid-lowering therapy on vascular stiffness in patients with gout by Wooseong Jeong, Jinseok Kim

Subjects: Get full text

Battle of the strategies: diet versus drug therapy for gout by O. V. Zhelyabina, M. S. Eliseev, A. M. Lila

Subjects: Get full text

A comparison of efficacy of Febuxostat and allopurinol in treatment of hyperuricemia in patients with chronic renal failure by CAI Hui, SU Xiao-juan, HUA Jin-cheng, LIANG Meng

Subjects: “…Febuxostat…”
Get full text

The use of febuxostat in comorbid patients with gout in real clinical practice: own data by E. V. Zonova, D. N. Orlov, A. S. Kabargina

Subjects: Get full text

Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story by M. S. Eliseev, O. V. Zhelyabina

Subjects: “…febuxostat…”
Get full text

Urate-lowering therapy for heart failure by O. V. Zhelyabina, M. S. Eliseev

Subjects: Get full text

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota by M. S. Eliseev, E. N. Kharlamova, O. V. Zhelyabina, A. M. Lila

Subjects: Get full text

Rational use of recommendations for urate-lowering therapy: clinical examples by M. S. Eliseev, O. V. Zhelyabina

Subjects: Get full text

Efficacy of febuxostat on hyperuricemia and estimated glomerular filtration rate in patients with non-dialysis stage 3/4 chronic kidney disease and assessment of cardiac function:... by Yousuf Abdulkarim Waheed, Yousuf Abdulkarim Waheed, Fan Yang, Jie Liu, Shifaa Almayahe, Karthick Kumaran Munisamy Selvam, Disheng Wang, Disheng Wang, Disheng Wang, Dong Sun, Dong Sun, Dong Sun

Subjects: “…febuxostat…”
Get full text

Bridging the evidence-practice gap for people with gout by Mark D. Russell, James B. Galloway

Subjects: Get full text

Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy by M. S. Eliseev

Subjects: Get full text

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with rena... by Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima

Subjects: “…febuxostat…”
Get full text

Impact of urate-lowering therapy on quality of life indicators in patients with gout by M. N. Chikina, O. V. Zhelyabina, M. S. Eliseev

Subjects: Get full text